皮肤上对猫的皮肤下注布罗塞米德的副作用
Chiara Mazzoldi1, Francesca Aspidi1, Giovanni Romito1
1Department of Veterinary Medical Sciences, Alma Mater Studiorum-University of Bologna, Ozzano dell'Emilia, Italy.
Open veterinary journal
|September 13, 2023
概括
皮下注射的富罗塞米德 (SF) 可以引起猫的皮肤反应,这是以前在狗和人类身上记录的副作用. 这份报告详细介绍了在施用SF后疑似出现猫类皮肤病变的病例,强调了兽医领域的潜在不良影响.
科学领域:
- 兽医皮肤病学 兽医皮肤病学
- 小动物医学 小动物医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 富罗塞米德是治疗猫和狗充血性心力衰竭 (CHF) 的关键性利尿剂.
- 皮肤下注富洛塞米德 (SF) 的皮肤不良影响已知在狗和人类医学中.
- 在猫科动物患者中以前没有报告过对SF的皮肤反应.
研究的目的:
- 报告第一例疑似皮肤学不良影响的皮肤下注布罗塞米德在猫.
- 提高对猫科动物患者与SF相关的潜在皮肤反应的认识.
主要方法:
- 一只患有心血管梗塞的2岁家用短毛猫接受了各种发胺配方的治疗.
- 当口服和静脉注射途径不足或不切实际时,皮肤下注射富洛塞米德.
- 猫在注射部位出现了皮肤病变,导致罗塞米德品牌的变化.
主要成果:
- 这只猫在SF注射部位出现了明显的状性皮肤病变,并出现了脱发.
- 这些病变在转换到替代品牌的罗塞米德后的一个月内消失.
- 转换罗西米德品牌也防止了进一步的肺的发作,而不会再次出现皮肤问题.
结论:
- 皮下注射的罗塞米德可以在猫身上引起罕见但显著的皮肤学副作用.
- 兽医在给猫患者开处方时,应注意这种潜在的副作用.
- 切换furosemide品牌可能会解决这些不良皮肤反应,同时保持治疗疗效.
相关概念视频
Heart Failure Drugs: Diuretics
418
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
418
Renal Failure: Dose Adjustments
115
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
115
Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Antihypertensive Drugs: Thiazide-Class Diuretics
738
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
738
Acute Kidney Injury V: Interprofessional Care
25
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
25


